The Ministry of Health (Minsa) of Panama announced that the Directorate of Pharmacies and Drugs has already begun the process of reviewing the portfolio of the Chinese Sinovac vaccine against covid-19.
The entity indicated that it is the vaccine
with series 004-DNFD and once the review process is concluded it would be the fourth vaccine
with authorization for emergency use in the country.
This week, Farmacias y Drogas authorized the emergency use of the Russian vaccine
Sputnik V, after concluding with the reviews of the dossier.
Currently in the country the preparation of the American pharmaceutical company Pfizer
is being applied, with which 450 thousand doses were agreed for the first quarter of this year.
It was also confirmed that Panama will receive some 216 thousand doses of the AstraZeneca covid
, through the Covax mechanism promoted by the World Health Organization (WHO).
Regarding the reports of a possible relationship between this formula with cases of thrombosis, the Minister of Health, Luis Sucre
said that the reports of international health organizations have ruled this out and no one will be forced to apply it.